Provided by Tiger Trade Technology Pte. Ltd.

TRAD CHI MED

1.295
-0.015-1.15%
Volume:7.89M
Turnover:10.24M
Market Cap:6.52B
PE:-16.33
High:1.310
Open:1.310
Low:1.290
Close:1.310
52wk High:2.680
52wk Low:1.290
Shares:5.04B
HK Float Shares:5.04B
Volume Ratio:1.12
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.079
ROE:-5.05%
ROA:0.34%
PB:0.28
PE(LYR):-16.33
PS:0.44

Loading ...

TRAD CHI MED Confirms Stable Share Base and Adequate Public Float for June 2026

Bulletin Express
·
Jul 02

China Traditional Chinese Medicine: All AGM Resolutions Secure ≥94% Approval

Bulletin Express
·
Jun 26

China Traditional Chinese Medicine Holdings AGM Passes All Resolutions by Poll

Reuters
·
Jun 26

TRAD CHI MED Sets 26 June 2026 AGM to Review 2025 Results, Re-elect Directors and Renew Auditor

Bulletin Express
·
May 29

TRAD CHI MED Publishes AGM Circular and Confirms Transition to Full Electronic Corporate Communications

Bulletin Express
·
May 29

TRAD CHI MED Sets 26 Jun 2026 AGM and Formalises Full E-Communication for Shareholders

Bulletin Express
·
May 29

China Traditional Chinese Medicine Announces Board Reshuffle: Liu Haijian Resigns, Chen Kun Appointed as Non-Executive Director

Bulletin Express
·
May 15

TRAD CHI MED Announces Board Reshuffle: Chen Kun Appointed as Non-Executive Director and Committee Member

Stock News
·
May 15

China Traditional Chinese Medicine Holdings files directors list with Hong Kong exchange

Reuters
·
May 15

China Traditional Chinese Medicine names Chen Kun as non-executive director

Reuters
·
May 15

TRAD CHI MED's Subsidiaries Gain Approval for Two Classical Herbal Formulations in Granule Form

Stock News
·
May 11

China Traditional Chinese Medicine (China TCM) wins NMPA nod for two ancient-formula granules

Bulletin Express
·
May 11

China TCM wins China approval for Shaoyao Gancao Tang granules

Reuters
·
May 11

China Traditional Chinese Medicine Holdings - Receives Drug Approval Licenses From China National Medical Products Administration

THOMSON REUTERS
·
May 11

China Traditional Chinese Medicine Holdings - Shaoyao Gancao Tang and Taohe Chengqi Tang Granules Approved for Marketing

THOMSON REUTERS
·
May 11

TRAD CHI MED Announces 2025 Annual Report Release and Transition to Full E-Communication

Bulletin Express
·
Apr 28

China TCM issues 2025 ESG report

Reuters
·
Apr 28

中药控股聚焦核心业务转型:2025年营收147.44779亿元,同比降10.7%,净亏4.5809亿元

Bulletin Express
·
Apr 28

China Traditional Chinese Medicine publishes 2025 annual report

Reuters
·
Apr 28

China TCM’s 2025 ESG Report: RMB 511.47 Million R&D Outlay, 2.65% CO₂-Intensity Cut and Expanded Green Factory Network

Bulletin Express
·
Apr 28